ReviewPharmaceuticals (Basel, Switzerland)2014

Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors.

Hiroshi FujiwaraPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.